Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuronetics (STIM) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for Neuronetics (STIM) over the last 7 years, with Q3 2025 value amounting to -$0.13.

  • Neuronetics' EPS (Weighted Average and Diluted) rose 7045.45% to -$0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.83, marking a year-over-year increase of 3196.72%. This contributed to the annual value of -$1.32 for FY2024, which is 2559.46% down from last year.
  • As of Q3 2025, Neuronetics' EPS (Weighted Average and Diluted) stood at -$0.13, which was up 7045.45% from -$0.15 recorded in Q2 2025.
  • In the past 5 years, Neuronetics' EPS (Weighted Average and Diluted) ranged from a high of -$0.13 in Q3 2025 and a low of -$0.44 during Q3 2024
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.29, with a median of -$0.3 in 2022.
  • In the last 5 years, Neuronetics' EPS (Weighted Average and Diluted) plummeted by 13159.53% in 2024 and then skyrocketed by 7045.45% in 2025.
  • Neuronetics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.28 in 2021, then dropped by 7.14% to -$0.3 in 2022, then skyrocketed by 40.0% to -$0.18 in 2023, then plummeted by 131.6% to -$0.42 in 2024, then skyrocketed by 68.82% to -$0.13 in 2025.
  • Its last three reported values are -$0.13 in Q3 2025, -$0.15 for Q2 2025, and -$0.21 during Q1 2025.